Mass tag-assisted identification of naturally processed HLA class II-presented meningococcal peptides recognized by CD4+ T lymphocytes

Journal of Immunology

Volumn 174, Issue 9, 2005, Pages 5636-5643

  Meiring, Hugo D ^a   Kuipers, Betsy ^b   Van Gaans Van Den Brink, Jacqueline A M ^b   Poelen, Martien C M ^b   Timmermans, Hans ^b   Baart, Gino ^b   Brugghe, Humphrey ^b   Van Schie, Joost ^b   Boog, Claire J P ^b   De Jong, Ad F J M ^a   Van Els, Cécile A C M ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b NETHERLANDS VACCINE INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; HLA ANTIGEN CLASS 2; HLA DR1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MENINGOCOCCUS VACCINE; PORIN; PORIN A; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOTOPE LABELING; MASS SPECTROMETRY; MEMORY CELL; MENINGOCOCCEMIA; METHODOLOGY; NEISSERIA MENINGITIDIS; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE; T LYMPHOCYTE;

EID: 20944433397     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.9.5636     Document Type: Article

References (47)

1. Rosenstein, N. E., B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes. 2001. Meningococcal disease. N. Engl. J. Med. 344:1378.
2. Jodar, L., I. M. Feavers, D. Salisbury, and D. M. Granoff. 2002. Development of vaccines against meningococcal disease. Lancet 359:1499.
3. de Kleijn, E., L. van Eijndhoven, C. Vermont, B. Kuipers, H. van Dijken, H. Rumke, R. de Groot, L. van Alphen, and G. van den Dobbelsteen. 2001. Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine. Vaccine 20:352.
4. de Kleijn, E. D., R. de Groot, J. Labadie, A. B. Lafeber, G. van den Dobbelsteen, L. van Alphen, H. van Dijken, B. Kuipers, G. W. van Omme, M. Wala, et al. 2000. Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age. Vaccine 18:1456.
5. Rouppe van der Voort, E. M., V. M. Schuller, J. Holst, P. de Vries, P. van der Ley, G. van den Dobbelsteen, and J. Poolman. 2000. Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys. Vaccine 18:1334.
6. Oftung, F., L. M. Naess, L. M. Wetzler, G. E. Korsvold, A. Aase, E. A. Hoiby, R. Dalseg, J. Holst, T. E. Michaelsen, and B. Haneberg. 1999. Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine. Infect. Immun. 67:921.
7. Davenport, V., T. Guihrje, J. Findlow, R. Borrow, N. A. Williams, and R. S. Heyderman. 2003. Evidence for naturally acquired T cell-mediated mucosal immunity to Neisseria meningitidis. J. Immunol. 171:4263.
8. Wiertz, E. J., A. Delvig, E. M. Donders, H. F. Brugghe, L. M. van Unen, H. A. Timmermans, M. Achtman, P. Hoogerhoul, and J. T. Poolman. 1996. T-cell responses 10 outer membrane proteins of Neisseria meningitidis: comparative study of the Opa, Ope, and PorA proteins. Infect. Immun. 64:298.
9. Wiertz, E. J., J. A. van Gaans-van den Brink, H. Gausepohl, A. Prochnicka-Chalufour, P. Hoogerhout, and J. T. Poolman. 1992. Identification of T cell epitopes occurring, in a meningococcal class I outer membrane protein using overlapping peptides assembled with simultaneous multiple peptide synthesis. J. Exp. Med. 176:79.
10. Watts, C. 2004. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat. Immunol. 5:685.
11. Yewdell, J. W., and J. R. Bennink. 2001. Cut and trim: generating MHC class I peptide ligands. Curr. Opin. Immunol 13:13.
12. Rotzschke, O., K. Falk, S. Stevanovic, G. Jung, P. Walden, and H. G. Rammensee. 1991. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21:2891.
13. + cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J. Exp. Med. 189:871.
14. Chicz, R. M., R. G. Urban, J. C. Gorga, D. A. Vignali, W. S. Lane, and J. L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27.
15. Rammensee, H. G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
16. Dengjel, J., P. Decker, O. Schoor, F. Altenberend, T. Weinschenk, H. G. Rammensee, and S. Stevanovic. 2004. Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectrometry. Eur. J. Immunol. 34:3644.
17. Engelhard, V. H., A. G. Brickner, and A. L. Zarling. 2002. Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire. Mol. Immunol. 39:127.
18. +-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene product. Infect. Immun. 70:2926.
19. Peakman, M., E. J. Stevens, T. Lohmann, P. Narendran, J. Dromey, A. Alexander, A. J. Tomlinson, M. Trucco, J. C. Gorga, and R. M. Chicz. 1999. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. J. Clin. Invest 104:1449.
20. Phelps, R. G., A. N. Turner, and A. J. Rees. 1996. Direct identification of naturally processed autoantigen-derived peptides bound to HLA-DR15. J. Biol. Chem. 271:18549.
21. Seamons, A., J. Sutton, D. Bai, E. Baird, N. Bonn, B. F. Kafsack, J. Shabanowitz, D. F. Hunt, C. Beeson, and J. Goverman. 2003. Competition between two MHC binding registers in a single peptide processed from myelin basic protein influences tolerance and susceptibility to autoimmunity. J. Exp. Med. 19;197:1391.
22. van Els, C. A., C. A. Herberts, E. van der Heeft, M. C. Poelen, J. A. van Gaans-van den Brink, A. van der Kooi, P. Hoogerhout, G. J. ten Hove, H. D. Meiring, and A. P. de Jong. 2000. A single naturally processed measles virus peptide fully dominates the HLA-A*0201-associated peptide display and is mutated at its anchor position in persistent viral strains. Eur. J. Immunol. 30:1172.
23. Vignali, D. A., R. G. Urban, R. M. Chiez, and J. I., Strominger. 1993. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. Eur. J. Immunol. 23:1602.
24. Peeters, C. C., H. C. Rumke, L. C. Sundermann, E. M. Rouppe van der Voort, J. Meulenbelt, M. Schuller, A. J. Kuipers, P. van der Ley, and J. T. Poolman. 1996. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 14:1009.
25. Jyssum, K. 1959. Assimilation of nitrogen in meningococci grown with the ammonium ion as sole nitrogen source. Acta Path. Microbiol. Scand. 46:320.
26. Claassen, I., J. Meylis, P. van der Ley, C. Peeters, H. Brons, J. Robert, D. Borsboom, A. van der Ark, I. van Straaten, P. Roholl, et al. 1996. Production, characterization and control of a Neisseria meningitidis hexavalent class I outer membrane protein containing vesicle vaccine. Vaccine 14:1001.
27. (n): technical design and applications to peptide and protein analysis. J. Sep. Sci. 25:557.
28. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109.
29. Van Bleek, G. M., M. C. Poelen, R. G. van der Most, H. F. Bruggbe, H. A. Timmermans, C. J. Boog, P. Hoogerhout, H. G. Often, and C. A. van Els. 2003. Identification of immune dominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells. J. Virol. 77:980.
30. de Vries, I. J., A. A. Eggert, N. M. Scharenborg, J. L. Vissers, W. J. Lesterhuis, O. C. Boerman, C. J. Punt, G. J. Adema, and C. G. Figdor. 2002. Phenotypical and functional characterization of clinical grade dendritic cells. J. Immunother. 25:429.
31. Aebersold, R., and M. Mann. 2003. Mass spectrometry-based proteomics. Nature 422:198.
32. Nepom, G. T., J. D. Lippolis, F. M. White, S. Masewicz, J. A. Marto, A. Herman, C. J. Luckey, B. Falk, J. Shabanowitz, D. F. Hunt, et al. 2001. Identification and modulation of a naturally processed T cell epitope from the diabetes-ssociated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc. Natl. Acad. Sci. USA 98:1763.
33. Ovsyannikova, I. G., K. L. Johnson, S. Naylor, and G. A. Poland. 2000. Isolation and rapid identification of an abundant self-peptide from class II HLA-DRB1z.ast;0401 alleles induced by measles vaccine virus infection. J. Immunol. Methods 246:1.
34. Gordon, R. D., J. A. Young, S. Rayner, R. W. Luke, M. L. Crowther, P. Wordsworth, J. Bell, G. Hassall, J. Evans, S. A. Hinchliffe, et al. 1995. Purification and characterization of endogenous peptides extracted from HLA-DR isolated from the spleen of a patient with rheumatoid arthritis. Eur. J. Immunol. 25:1473.
35. Muntasell, A., M. Canascal, L. Senadell, P. P. Veelen, F. Verreck, F. Koning, G. Raposo, J. Abian, and D. Jaraquemada. 2002. HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides. J. Immunol. 169:5052.
36. Reis e Sousa, C. 2001. Dendritic cells as sensors of infection. Immunity 14:495.
37. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782.
38. Lippolis, J. D., F. M. White, J. A. Marto, C. J. Luckey, T. N. Bullock, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 2002. Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J. Immunol. 169:5089.
39. van der Ley, P., J. E. Heckels, M. Virji, P. Hoogerhout, and J. T. Poolman. 1991. Topology of outer membrane porins in pathogenic Neisseria spp. Infect. Immun. 59:2963.
40. Cowan, S. W., T. Schirmer, G. Rummel, M. Steiert, R. Ghosh, R. A. Pauptit, J. N. Jansonius, and J. P. Rosenbusch. 1992. Crystal structures explain functional properties of two E. coli porins. Nature 358:727.
41. Stem, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
42. Sercarz, E. E., P. V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729.
43. Anderton, S. M., N. J. Viner, P. Matharu, P. A. Lowrey, and D. C. Wraith. 2002. Influence of a dominant cryptic epitope on autoimmune T cell tolerance. Nat. Immunol. 3:175.
44. Antoniou, A. N., S. L. Blackwood, D. Mazzeo, and C. Watts. 2000. Control of antigen presentation by a single protease cleavage site. Immunity 12:391.
45. Manoury, B., D. Mazzeo, L. Fugger, N. Viner, M. Ponsford, H. Streeter, G. Mazza, D. C. Wraith, and C. Watts. 2002. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat. Immunol. 3:169.
46. Pluger, E. B., M. Boes, C. Alfonso, C. J. Schroter, H. Kalbacher, H. L. Ploegh, and C. Driessen. 2002. Specific role for cathepsin S in the generation of antigenic peptides in vivo. Eur. J. Immunol. 32:467.
47. Sercarz, E. E., and E. Maverakis. 2003. Mhc-guided processing: binding of large antigen fragments. Nat. Rev. Immunol. 3:621.